In the article, the US trauma surgeon (Mark Fleming) talks about his use of spray on skin after trauma. Presumably that was the technology co-invented by Professor Fiona Woods AO (now commercialised by Avita Medical), who just happens to be on our BOD. Maybe Prof Fiona Woods is the key connection here. In any case, he has been open to adopting innovative Australian breakthrough medical inventions in the past, so bodes well for Remplir.
A reminder also that both PA & JVDW visited and spoke to surgeons at Mass Gen around 2 months ago. So seems like all the preparatory work and discussions they’ve done in advance of approval is and will pay off.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)